Merck & Co., Inc.
MRK
$77.65
-$1.47-1.86%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.56% | 6.79% | 4.35% | 7.16% | 8.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.56% | 6.79% | 4.35% | 7.16% | 8.89% |
| Cost of Revenue | -1.20% | -2.32% | -8.11% | -7.84% | -12.14% |
| Gross Profit | -1.66% | 9.99% | 8.85% | 12.59% | 16.63% |
| SG&A Expenses | 3.71% | 1.89% | 8.63% | 0.39% | -1.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.56% | -32.72% | 24.44% | -0.63% | -2.87% |
| Operating Income | -7.14% | 916.67% | -28.26% | 19.30% | 30.25% |
| Income Before Tax | 4.11% | 303.81% | -27.22% | 212.58% | 55.34% |
| Income Tax Expenses | -9.41% | 151.95% | 6.78% | -14.44% | 9.45% |
| Earnings from Continuing Operations | 6.67% | 405.38% | -33.45% | 191.44% | 68.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -20.00% | -- | 20.00% | -100.00% | -25.00% |
| Net Income | 6.66% | 405.30% | -33.47% | 191.30% | 68.81% |
| EBIT | -7.14% | 916.67% | -28.26% | 19.30% | 30.25% |
| EBITDA | -4.45% | 2,492.37% | -21.97% | 19.52% | 24.62% |
| EPS Basic | 7.08% | 404.83% | -33.39% | 191.48% | 69.14% |
| Normalized Basic EPS | -6.05% | 620.63% | -24.73% | 17.25% | 27.26% |
| EPS Diluted | 7.49% | 404.83% | -33.33% | 190.94% | 68.47% |
| Normalized Diluted EPS | -5.95% | 620.63% | -24.67% | 16.78% | 27.37% |
| Average Basic Shares Outstanding | -0.39% | 0.16% | -0.12% | -0.20% | -0.20% |
| Average Diluted Shares Outstanding | -0.51% | 0.16% | -0.20% | 0.20% | -0.27% |
| Dividend Per Share | 5.19% | 5.48% | 5.48% | 5.48% | 5.48% |
| Payout Ratio | -0.01% | 1.35% | 0.58% | 2.15% | -0.38% |